Green Cross Corporation
KRX:006280.KS
166,100 (KRW) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Green Cross Corporation |
Symbool | 006280.KS |
Munteenheid | KRW |
Prijs | 168,700 |
Beurswaarde | 1,925,396,718,000 |
Dividendpercentage | 1.32% |
52-weken bereik | 93,000 - 177,500 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Il-Sup Huh Ph.D. |
Website | https://www.globalgreencross.com |
An error occurred while fetching data.
Over Green Cross Corporation
Green Cross Corporation, a biopharmaceutical company, develops drugs and vaccines in South Korea. The company provides plasma derivatives, including albumin, immunoglobulin, and antithrombin; and vaccines for hepatitis-B, Hantavirus hemorrhagic fever, influenza, flu, and varicella. It also offers prescription drugs for the bleeding symptom control and hemostasis for persons with hemophilia
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)